XML 42 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Note 20 - Segment Reporting
 12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]

NOTE 20. SEGMENT REPORTING

 

The Company’s chief operating decision maker (“CODM”), who is the Company’s Chief Executive Officer, allocates resources and assesses performance based on financial information of the Company. The CODM reviews financial information presented for each reportable segment for purposes of making operating decisions and assessing financial performance.

 

Prior to the DERMAdoctor Acquisition in November 2021 (see Note 3, “Business Combination”), the Company was managed as a single segment focused on commercializing Avenova Spray in the United States. After the DERMAdoctor Acquisition, the Company began managing and aggregating its operational and financial information in accordance with two reportable segments: (1) Optical & Wound Care and (2) Skin Care. The Optical & Wound Care segment consists of products historically sold by NovaBay prior to the DERMAdoctor Acquisition. The Skin Care segment consists of products acquired in the DERMAdoctor Acquisition and skincare products subsequently sold under the DERMAdoctor brand.

 

Select financial information for each segment is as follows:

 

  

Year

      

Year

     
  

Ended

  Percentage   

Ended

  Percentage  
  

December 31,

  

of Product

  

December 31,

  

of Product

 
  

2022

  

Revenue

  

2021

  

Revenue

 

Optical & Wound Care

 $10,239   71

%

 $9,555   94

%

Skin Care

  4,165   29

%

  649   6

%

Total sales, net

 $14,404   100

%

 $10,204   100

%

 

 

  Year      Year     
  Ended  Percentage  Ended  Percentage 
  December 31,   of Total   December 31,   of Total  
  2022  Operating Loss  2021  Operating Loss 

Optical & Wound Care

 $5,645   39

%

 $8,682   98

%

Skin Care

  8,772   61

%

  180   2

%

Total operating loss

 $14,417   100

%

 $8,862   100

%